Association of the ML Flow serologic test to slit skin smear.

Department of Sanitary Dermatology, Eduardo de Menezes Hospital, Hospital Foundation of Minas Gerais State, MG, Brazil.
Revista da Sociedade Brasileira de Medicina Tropical (Impact Factor: 0.98). 02/2008; 41 Suppl 2:23-6.
Source: PubMed


A descriptive, exploratory study was conducted analyzing the association of covariables in the results of the ML Flow serological test and slit skin smear. A total of 60 leprosy cases diagnosed at the state Sanitary Dermatology Referral Center were investigated. Slit skin smear samples were collected from four sites and the results were expressed by the bacillary index. ML Flow was registered in both qualitative and semi-quantitative terms. Cohen's kappa coefficient was used to study the agreement with Landis and Koch's observer criteria for interpretation. For statistical analysis, the logistic regression model and Kruskal-Wallis test were used. ML Flow showed a strong association with slit skin smear results, since a gradual increase in BI was accompanied by a semi-quantitative rise in antibody levels measured by ML Flow, with 100% positivity in cases presenting a positive slit skin smear. Given its strong correlation to slit skin smear, the results of this study provide evidence that the ML Flow test could be a valuable auxiliary tool in the classification and treatment of leprosy patients.

5 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Our aim was to compare the performance of three serological assays in leprosy patients and their household contacts utilising two quantitative ELISA tests using native PGL-I (PGL-1 ELISA), synthetic ND-O-HSA (ND-O-HSA ELISA), and the semi-quantitative lateral flow test (ML Flow). Comparisons among three immunological assays, PGL-I ELISA, ND-O-HSA ELISA, and ML Flow were performed in 154 leprosy patients, 191 household contacts and 52 health subjects. The sensitivity results of the PGL-1, ND-O-HSA, and ML Flow were 68.83%, 63.84%, and 60.65%, respectively, with specificity of 98% for both ELISA assays. The native and synthetic PGL-I ELISA assays detected antibodies in 22.73% and 31.82% of the paucibacillary (PB) patients, respectively and the ML Flow test did not detect antibodies in this group. The ML Flow test was able to discriminate patients into PB or multibacillary (MB) forms, while the native PGL-I and ND-O-HSA was correlated with the bacillary load and the Ridley-Jopling clinical forms. In household contacts, the native PGL-I, ND-O-HSA, and ML Flow assays detected seropositivity of 25%, 17%, and 10%, respectively. The use of ELISA and ML Flow tests are thus recommended as additional tools in the diagnosis and classification of the clinical forms, aiding in prescribing the correct treatment regimen to prevent subsequent nerve damage and disability, and besides, the PGL-I ELISA may be used to detect subclinical infection in leprosy.
    Leprosy review 12/2011; 82(4):389-401. · 0.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Leprosy is a disease caused by Mycobacterium leprae that carries a high risk of disability, making early diagnosis mandatory. This study aimed to determine the applicability of anti-PGL-1 IgM antibody detection, using the ML FLOW technique, as an assistant tool for the detection of leprosy infection in asymptomatic household contacts (AHHC) of multibacillary leprosy index cases from Midwest Brazil. Serological changes induced by the prophylaxis of these household contacts with Bacillus Calmette-Guérin (BCG) were also verified. A total of 91 AHHC were assessed, among which, 18.68% (n = 17) presented both positive bacilloscopy and positive anti-PGL-1 IgM serology. Positivity concordance between these two laboratorial exams (Kappa Index = 1; p < 0.001) was indicated, however, one case did not demonstrate concordance between the semiquantitative assessment of anti-PGL-1 IgM and the bacilloscopy index (Kappa Index = 0.96; p < 0.001). Among the 17 AHHC with positive bacilloscopy, eight were reassessed after prophylaxis with BCG and two of them presented negative anti-PGL-1 IgM serology, being these patients who had presented a bacilloscopy index of < 2[+] in the initial assessment. This study shows that anti-PGL-1 IgM detection may be used as a tool to determine the bacillary load in AHHC and to detect immune changes related to prophylaxis by nonspecific vaccination.
    Revista do Instituto de Medicina Tropical de São Paulo 05/2013; 55(3). DOI:10.1590/S0036-46652013000300006 · 1.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: This reserach aimed to determine the correlation between the morphology index and IgM anti PGL-1, and the mutations in gyrA genes in order to detect ofloxacin resistance in the patients with multibacillary (MB) leprosy. Methods: This research was conducted in Dr. Wahidin Sudirohusodo General Hospital and its network hospitals in Makassar using the cohort retrospective design. The research sample comprised 21 patients with MB leprosy who had completed the ROM treatment regimens, and whose bacterial index (BI), morphology index (MI), IgM anti PGL-1 antibody, PCR, and sequencing, skin lesion number, and treatment regularity had been examined. Result: The research revealed that all the samples did not undergo any mutations of the gyrA genes which was responsible for the ofloxacin resistance; however, there was a correlation between BI and the IgM anti PGL-1 antibody, and between IgM anti PGL-1 antibody and the number of the skin lesions. Conclusions: There was no samples found to undergo the mutations of gyrA genes, this could be used as the reference to assess the correlation between the morphology index and the IgM anti PGL-1 antibody with the mutations of the gyrA genes.

Similar Publications